1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  05/27 11:35:29 am EDT
3.614 EUR   +4.75%
05/26European ADRs Move Higher in Thursday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/24Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Friday Trading

01/21/2022 | 11:11am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC -3.69% 1.175 Delayed Quote.-18.67%
ARCELORMITTAL 3.24% 30.445 Real-time Quote.4.78%
AVADEL PHARMACEUTICALS PLC 130.07% 2.4611 Delayed Quote.-86.76%
BHP GROUP LIMITED 2.46% 43.67 Delayed Quote.2.70%
BIOFRONTERA AG 0.90% 1.125 Delayed Quote.-24.66%
BIONTECH SE 4.45% 164.9 Delayed Quote.-38.65%
BRITISH AMERICAN TOBACCO PLC -0.39% 3550.5 Delayed Quote.30.40%
CELLECTIS S.A. 4.75% 3.614 Real-time Quote.-53.63%
EDAP TMS S.A. -0.63% 7.095 Delayed Quote.19.20%
MEREO BIOPHARMA GROUP PLC 8.58% 0.5201 Delayed Quote.-70.06%
NATUZZI S.P.A. -2.05% 9.57 Delayed Quote.-39.92%
NUCANA PLC -2.50% 0.6045 Delayed Quote.-73.95%
TRINITY BIOTECH PLC 3.42% 1.4272 Delayed Quote.-3.50%
UNILEVER PLC -0.36% 3475.5 Delayed Quote.-11.60%
VIA OPTRONICS AG -0.19% 2.5 Delayed Quote.-65.92%
All news about CELLECTIS S.A.
05/26European ADRs Move Higher in Thursday Trading
MT
05/25European ADRs Move Lower in Wednesday Trading
MT
05/24Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
05/24Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23CELLECTIS S A : ' Annual Shareholders' General Meeting to be Held on June 28, 2022 - Form ..
PU
05/23Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
GL
05/23Cellectis' Annual Shareholders' General Meeting to be Held on June 28, 2022
AQ
05/23CELLECTIS S A : Consolidated Financial Statements - Form 6-K
PU
05/20CALYXT, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand..
AQ
05/20European ADRs Move Sharply Higher in Friday Trading
MT
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2022 66,3 M 71,1 M 71,1 M
Net income 2022 -83,2 M -89,1 M -89,1 M
Net cash 2022 41,5 M 44,4 M 44,4 M
P/E ratio 2022 -1,56x
Yield 2022 -
Capitalization 157 M 168 M 168 M
EV / Sales 2022 1,74x
EV / Sales 2023 -1,28x
Nbr of Employees 297
Free-Float 84,3%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 3,45 €
Average target price 16,00 €
Spread / Average Target 364%
EPS Revisions
Managers and Directors
André Choulika Chief Executive Officer & Director
Bing C. Wang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Carrie Brownstein Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-53.63%168
MODERNA, INC.-46.53%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-26.37%39 319
SEAGEN INC.-10.44%25 487
ICON PUBLIC LIMITED COMPANY-29.73%17 693